NR 546 Final PRACTICE EXAM Psychopharmacology Questions And Answers
MAOIs (monoamine oxidase inhibitors) attect which neu-rotransmitters? A. Serotonin, Dopamine, Norepinephrine B. Serotonin, GABA, Glutamate C. Acetylcholine, Dopamine, Norepinephrine D. Dopamine, GABA, Acetylcholine Which of the following is considered first line treatment for depression? A. SSRI B. FGA C. SNRI D. MAOI When treating a patient for major depression disorder which medication would the PMHNP consider first? A. Depakote B. Selegiline C. Escitalopram D. Isocarboxazid Which of the following medication should be considered for a patient diagnosed with major depressive disorder who reports "always forgetting to take my pills"? A. Mirtazapine B. Fluvoxamine C. Fluoxetine D. Carbemazepine Which of the following medication has a black box warn-ing of a life-threatening skin rash?
Written for
- Institution
- NR 546
- Course
- NR 546
Document information
- Uploaded on
- June 27, 2026
- Number of pages
- 24
- Written in
- 2025/2026
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
- nr 546
- questions and answers
-
nr 546 final practice exam psychopharmacology